top of page
Center of NewÂ
Biotechnologies & Precision
Medicine
Â
Enabling precision prognosis, diagnosis & therapy of diseases through advances in Biotechnology
The GreekÂ
Research Infrastructure for Personalised Îœedicine
Â
Towards more accurate and cost-effective health management for the Greek citizen
Our Goals
​​​
-
Strengthen basic research
-
Harness the “big data” revolution
-
Revise clinical trial designs
-
Move regulatory science forward
-
Foster collaboration
-
Enhance patient access to innovative medicines
​
A specialized regional
“meta-structure”
-
Pharmaceutical R&D departments
-
Biotechnology SMEs and diagnostics developers
-
Biomedical and clinical researchers
-
National and European biomedical research infrastructures
-
Patients and patient foundations
-
Policy-makers
Scope
Â
pMedGR aims at supporting research and innovation towards next generation healthcare applications. Specifically, the infrastructure aims at re-designing ongoing and prospective clinical trials, linking them with molecular profiles obtained through high-throughput ‘omics’ technologies towards more efficient and cost-effective health and disease management for European citizens.
Â
pMedGR offers a unique opportunity for obtaining real added value for the European and regional social market economy and has a high potential for attracting private investments, maximizing synergies between national and EU funding schemes and thus mobilizing, leveraging and bundling different types of public and private funding. It combines economic viability with high-socioeconomic returns in the area of healthcare management and brings together the industrial sector, clinicians, medical researchers, biomedical scientists and technology experts, thus providing the necessary means to initiate and develop innovation.
News & Events
08-06-2021
​
Webinar Mass Cytometry (CyTOF): Dr K. Vetsika will give a presentation at a seminar on "Single-cell Proteomics: How to measure more than 40 parameters without compensation or background".
​
bottom of page